Skip to content
Search

Latest Stories

RPS, GPhC issue joint statement on professional and regulatory standards

All pharmacy owners, pharmacists and technicians are expected to be aware of and use all relevant standards, both regulatory and professional, to support them in their work.

The joint statement published by on Wednesday (June 15) by the Royal Pharmaceutical Society and General Pharmaceutical Council (GPhC) explains the difference between regulatory and professional standards and how they work together to provide a framework for professional practice and patient care.


It states: “All standards set by the GPhC work to improve the quality and safety of services provided to patients and the public. Regulatory standards must be met by all pharmacy professionals and owners of registered pharmacies, otherwise their registration may be at risk.

“Following professional and regulatory standards will help pharmacists, pharmacy technicians and pharmacy owners deliver patient-centred care and good quality outcomes and ensure that members of the public receive safe and effective care.”

The statement also highlighted that while professional standards and guidance are not mandatory, they are developed and owned by the profession and set out what constitutes ‘good’ in terms of practice, systems of care, and working practices.

“Pharmacy professionals following professional standards and guidance set by the RPS should have confidence these help to meet the overarching regulatory standards set by the GPhC,” the two bodies said.

RPS chief executive Paul Bennett commented: “As the professional leadership body for pharmacists, we support our members by providing professional guidance in all areas of practice that challenge and empower them to achieve excellence. Both regulatory and professional standards have the same overarching purpose, to ensure high quality patient care.”

Chief executive of the GPhC Duncan Rudkin added: “As the regulator, we expect all pharmacists, pharmacy technicians and pharmacy owners to be aware of and use all relevant standards, both regulatory and professional, to support them in their work. This helps make sure that patients and the public receive safe and effective care.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less